Darya-Varia Laboratoria Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Darya-Varia Laboratoria Tbk. trades at Rp1,560 (market cap 1.74T, 4.1K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: Darya-Varia Laboratoria Tbk. is far larger — about 3× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (817.3K versus 4.1K). Which is the better fit depends on your goals.
| DVLA | LABS | |
|---|---|---|
Market Cap | 1.74T | 584.6B |
Volume | 4.1K | 817.3K |
Lot | 41 | 8.17K |
Turnover | 6.44M | 120.01M |
Average Price | 1,569.51 | 146.84 |
Value | 6.44M | 120.01M |
Indicative Equilibrium Price | — | 146 |
Indicative Equilibrium Volume | — | 59 |
Trailing returns across standard periods
Latest headlines on both assets
PT Darya-Varia Laboratoria Tbk (the Company) was established, under notarial deed No. 5 dated February 5, 1976 as amended byu deed No. 148 dated April 30, 1976 made before notary public Abdul Latief, S.H. The Company is specialized in the production of soft gelatin-based capsule.
Read more on DVLA →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →